{"id":"W2088947243","doi":"10.1016/j.ygyno.2014.05.016","title":"A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Adverse effect; Clinical endpoint; Oncology; Phases of clinical research; Endometrial cancer; Toxicity; Progressive disease; Progression-free survival; Tyrosine-kinase inhibitor; Cancer; Surgery; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003605082,0.0009391637,0.002162119,0.000485637,0.001152346,0.0009398109,0.0007181632,0.001768647,0.00565103],"category_scores_gemma":[0.003119521,0.0006342173,0.001699702,0.0006743354,0.001085949,0.0009732636,0.0005657169,0.002637819,0.0004993008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001294949,"about_ca_system_score_gemma":0.003236169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004120484,"about_ca_topic_score_gemma":0.01384856,"domain_scores_codex":[0.998801,0.0007935383,0.00004110352,0.0001735252,0.00008080833,0.0001099897],"domain_scores_gemma":[0.9974257,0.0006855931,0.0004010967,0.0001787035,0.0001475839,0.001161373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9304892,0.00648258,0.009373185,0.0004958372,0.001766778,0.0000893347,0.0002048917,0.0006720138,0.002540698,0.00018834,0.004958929,0.04273823],"study_design_scores_gemma":[0.904952,0.07688004,0.01403375,0.00004474413,0.0009614925,0.00006911845,0.00008019868,0.0003414583,0.0002277428,0.0001157985,0.002272889,0.00002072154],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980701,0.007779553,0.0003229307,0.002732079,0.0004243718,0.002635767,0.001528341,0.00006854862,0.003807538],"genre_scores_gemma":[0.9804989,0.004351233,0.00130945,0.002803823,0.0006737834,0.003147094,0.002645744,0.00003273671,0.004537268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00565103,"threshold_uncertainty_score":0.01906574,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04853611210948144,"score_gpt":0.3468916180640979,"score_spread":0.2983555059546164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}